Suppr超能文献

羟基红花黄色素A对血管紧张素II诱导的大鼠血管外膜成纤维细胞增殖及胶原合成的影响

Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.

作者信息

Yuan Wendan, Yang Dongxia, Sun Xuhong, Liu Wei, Wang Liang, Li Xiaoyan, Man Xuejing, Fu Qiang

机构信息

College of Basic Medicine, Binzhou Medical University Yantai, China.

Department of Ophthalmology, Yuhuangding Hospital Yantai, China.

出版信息

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5772-81. eCollection 2014.

Abstract
  1. examine the effects of hydroxysafflor yellow A (HSYA) on the proliferation, collagen and cytokine synthesis of vascular adventitial fibroblasts as induced by angiotensin II (Ang II) in normal Sprague-Dawley (SD) rats in vitro, and 2) to assess the effects of HSYA on morphological changes and collagen accumulation of vascular adventitia in spontaneously hypertensive rats (SHR) in vivo. In vitro experiment, vascular adventitial fibroblasts from SD rats were isolated, cultured, and divided into control groups, model groups and HSYA groups. Cell morphology of adventitial fibroblasts was assessed using laser confocal microscopy, while cell proliferation with the MTT assay, and collagen synthesis was determined using hydroxyproline chromatometry. Immunocytochemistry and reverse transcription PCR were used for detecting the expression of TGF-β1, MMP-1, α-SMA and NF-κB in adventitial fibroblasts. In vivo experiment, vascular adventitia proliferation and collagen synthesis were analyzed using hematoxylin-eosin and Sirius staining. Our results showed that: 1) in vitro experiment of SD rats, HSYA inhibited proliferative activity and collagen synthesis of adventitial fibroblasts as induced by Ang II, and the inhibitory effects of HSYA on the increased expression of MMP-1, TGF-β1, α-SMA and NF-κB p65 as induced by Ang II were assessed, and 2) in vivo experiment of SHR, histological analysis displayed fewer pathological changes of vascular adventitia in HSYA treatment groups as compared with no HSYA treatment groups, and MMP-1, TGF-β1, α-SMA and NF-κB p65 expression significantly reduced after HSYA treatment (P < 0.05). Our results revealed that HSYA treatment significantly decreased the amount of cytokines and collagen synthesis in vascular adventitia components. This study provides experimental evidence demonstrating that HSYA has the capacity to decrease vascular adventitia proliferation and hyperplasia during vascular remodeling.
摘要
  1. 研究羟基红花黄色素A(HSYA)对正常Sprague-Dawley(SD)大鼠血管外膜成纤维细胞在体外血管紧张素II(Ang II)诱导下的增殖、胶原蛋白和细胞因子合成的影响,以及2) 评估HSYA对自发性高血压大鼠(SHR)体内血管外膜形态变化和胶原蛋白积累的影响。在体外实验中,分离、培养SD大鼠的血管外膜成纤维细胞,并分为对照组、模型组和HSYA组。使用激光共聚焦显微镜评估外膜成纤维细胞的细胞形态,通过MTT法检测细胞增殖,并使用羟脯氨酸比色法测定胶原蛋白合成。采用免疫细胞化学和逆转录PCR检测外膜成纤维细胞中TGF-β1、MMP-1、α-SMA和NF-κB的表达。在体内实验中,使用苏木精-伊红和天狼星染色分析血管外膜增殖和胶原蛋白合成。我们的结果表明:1) 在SD大鼠的体外实验中,HSYA抑制了Ang II诱导的外膜成纤维细胞的增殖活性和胶原蛋白合成,并评估了HSYA对Ang II诱导的MMP-1、TGF-β1、α-SMA和NF-κB p65表达增加的抑制作用,以及2) 在SHR的体内实验中,组织学分析显示与未用HSYA治疗的组相比,HSYA治疗组血管外膜的病理变化较少,并且HSYA治疗后MMP-1、TGF-β1、α-SMA和NF-κB p65表达显著降低(P < 0.05)。我们的结果表明,HSYA治疗显著减少了血管外膜成分中细胞因子和胶原蛋白的合成量。本研究提供了实验证据,证明HSYA具有在血管重塑过程中减少血管外膜增殖和增生的能力。

相似文献

2
Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
J Pharm Pharmacol. 2016 Oct;68(10):1320-30. doi: 10.1111/jphp.12596. Epub 2016 Jul 26.
3
Effect of CTRP3 on activation of adventitial fibroblasts induced by TGF-β1 from rat aorta in vitro.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2199-208. eCollection 2014.
5
CYP2J2-Derived EETs Attenuated Angiotensin II-Induced Adventitial Remodeling via Reduced Inflammatory Response.
Cell Physiol Biochem. 2016;39(2):721-39. doi: 10.1159/000445663. Epub 2016 Jul 27.
6
Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Chin J Integr Med. 2018 Jan;24(1):32-39. doi: 10.1007/s11655-017-2094-z. Epub 2018 Jan 3.
7
Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Phytother Res. 2016 Apr;30(4):577-87. doi: 10.1002/ptr.5560. Epub 2016 Jan 18.
8
Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis.
Phytomedicine. 2024 Sep;132:155830. doi: 10.1016/j.phymed.2024.155830. Epub 2024 Jun 15.
10
Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
PLoS One. 2016 Apr 18;11(4):e0153409. doi: 10.1371/journal.pone.0153409. eCollection 2016.

引用本文的文献

1
Effects of Hydroxysafflor Yellow A (HSYA) on UVA-Induced Damage in HaCaT Keratinocytes.
Int J Mol Sci. 2024 Jul 10;25(14):7573. doi: 10.3390/ijms25147573.
3
Therapeutic Potential of Hydroxysafflor Yellow A on Cardio-Cerebrovascular Diseases.
Front Pharmacol. 2020 Sep 29;11:01265. doi: 10.3389/fphar.2020.01265. eCollection 2020.
4
Wound Healing and the Use of Medicinal Plants.
Evid Based Complement Alternat Med. 2019 Sep 22;2019:2684108. doi: 10.1155/2019/2684108. eCollection 2019.
5
Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.
Evid Based Complement Alternat Med. 2018 Sep 25;2018:8259280. doi: 10.1155/2018/8259280. eCollection 2018.

本文引用的文献

2
Trophoblasts and decidual stromal cells regulate decidual NK cell functions via interaction between collagen and LAIR-1.
Am J Reprod Immunol. 2014 Apr;71(4):368-78. doi: 10.1111/aji.12211. Epub 2014 Feb 18.
4
The effects of hydroxysafflor yellow A on blood pressure and cardiac function.
J Ethnopharmacol. 2012 Feb 15;139(3):746-50. doi: 10.1016/j.jep.2011.11.054. Epub 2011 Dec 17.
5
Adventitial biology: differentiation and function.
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1523-9. doi: 10.1161/ATVBAHA.110.221176.
6
Recent advances on the role of cytokines in atherosclerosis.
Arterioscler Thromb Vasc Biol. 2011 May;31(5):969-79. doi: 10.1161/ATVBAHA.110.207415.
8
Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.
Am J Physiol Lung Cell Mol Physiol. 2009 Nov;297(5):L864-70. doi: 10.1152/ajplung.00128.2009. Epub 2009 Aug 21.
9
Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?
Eur Respir J. 2009 Jul;34(1):145-55. doi: 10.1183/09031936.00084808.
10
Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
J Cardiovasc Pharmacol. 2009 Feb;53(2):179-86. doi: 10.1097/FJC.0b013e318199f30b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验